GPCR
Structure Therapeutics Inc. American Depositary SharesNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$3.08B
P/E Ratio
—
EPS
$-2.64
Beta
-1.42
52W High
$94.90
52W Low
$15.80
50-Day MA
$43.64
200-Day MA
$47.60
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Structure Therapeutics Inc. American Depositary Shares
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. The company is headquartered in South San Francisco, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-185.13M |
| Operating Margin | 0.00% |
| Return on Equity | -11.90% |
| Return on Assets | -9.39% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $21.41 |
| Price-to-Book | 2.12 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -13.46 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $71.08M |
| Float | $54.73M |
| % Insiders | 2.66% |
| % Institutions | 96.09% |
Historical Volatility
HV 10-Day
62.20%
HV 20-Day
56.62%
HV 30-Day
52.50%
HV 60-Day
55.78%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($104.59 target)
4
Strong Buy11
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026